Racial/ethnic disparities in the treatment of localized/regional prostate cancer

Journal of Urology

Volumn 171, Issue 4, 2004, Pages 1504-1507

  Underwood, Willie ^a,b,d   DeMonner, Sonya ^a,d   Ubel, Peter ^c,d,e   Fagerlin, Angela ^c,d,e   Sanda, Martin G ^b   Wei, John T ^b,f  

^a Robert Wood Johnson Clinical Scholars Program   (United States)

^b Department of Urology   (United States)

^c Division of General Medicine   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Department of Physical Medicine and Rehabilitation   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

African continental ancestry group; European continental ancestry group; Hispanic Americans; Prostate; prostatic neoplasms

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; HEALTH CARE UTILIZATION; HISPANIC; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RACE DIFFERENCE; REGISTER; SOCIAL ASPECT; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR DIFFERENTIATION; UNITED STATES;

EID: 1642305564     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000118907.64125.e0     Document Type: Article

References (20)

1. Jemal, A., Murray, T., Samuals, A., Ghafoor, A., Ward, E. and Thun, M. J.: Cancer statistics, 2003. CA Cancer J Clin, 53: 5, 2003
2. Pienta, K. J., Demers, R., Hoff, M., Kau, T. Y., Montie, J. E. and Severson, R. K.: Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology, 45: 93, 1995
3. Schapira, M. M., McAuliffe, T. L. and Nattinger, A. B.: Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease. Med Care, 33: 1079, 1995
4. Harlan, L., Brawley, O., Pommerenke, F., Wali, P. and Kramer, B.: Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol, 13: 93, 1995
5. Harlan, L. C., Potosky, A., Gilliland, F. D., Hoffman, R., Albertsen, P. C., Hamilton, A. S. et al: Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst, 93: 1864, 2001
6. Powell, I., Gelfand, D., Parzuchowski, M., Heilbrun, L. and Franklin, A.: A successful recruitment process of African American men for early detection of prostate cancer. Cancer, suppl., 75: 1880, 1995
7. Yax, L. K.: Census Bureau National Population Estimates by Race and Hispanic Origin, Selected Years from 1990 to 2000. Available at http://eire.census.gov/popest/archives/national/nationa3.php. Accessed April 2, 2002
8. Gilliland, F. D., Hunt, W. C. and Key, C. R.: Trends in the survival of American Indian, Hispanic, and Non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994. Cancer, 82: 1769, 1998
9. Mettlin, C. J., Murphy, G. P., McDonald, C. J. and Menck, H. R.: The National Cancer Data Base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer, 86: 1877, 1999
10. SEER Program Code Manual, 3rd ed. Bethesda, Maryland: National Cancer Institute, 1998
11. Hankey, B. F., Ries, L. A. and Edwards, B. K.: The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev, 8: 1117, 1999
12. Albertsen, P. C., Hanley, J. A., Gleason, D. F. and Barry, M. J.: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA, 280: 975, 1998
13. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA, 274: 1599, 1995
14. Eastham, J. A. and Kattan, M. W.: Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. J Urol, 163: 143, 2000
15. Bach, P. B., Schrag, D., Brawley, O. W., Galaznik, A., Yakren, S. and Begg, C. B.: Survival of blacks and whites after a cancer diagnosis. JAMA, 287: 2106, 2002
16. Makridakis, N. M., Ross, R. K., Pike, M. C., Crocitto, L. E., Kolonel, L. N., Pearce, C. L. et al: Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet, 354: 975, 1999
17. Platz, E. A., Rimm, E. B., Willett, W. C., Kantoff, P. W. and Giovannucci, E.: Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst, 92: 2009, 2000
18. Fowler, F. J., Jr., McNaughton Collins, M., Albertsen, P. C., Zietman, A., Elliott, D. B. and Barry, M. J.: Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA, 283: 3217, 2000
19. Ferguson, J. A., Weinberger, M., Westmoreland, G. R., Mamlin, L. A., Segar, D. S., Greene, J. Y. et al: Racial disparity in cardiac decision making: results from patient focus groups. Arch Intern Med, 158: 1450, 1998
20. Stewart, S. L., Swallen, K. C., Glaser, S. L., Horn-Ross, P. L. and West, D. W.: Comparison of methods for classifying Hispanic ethnicity in a population-based cancer registry. Am J Epidemiol, 149: 1063, 1999